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Pigs are considered as important hosts or “mixing vessels” for the generation of pandemic 
influenza viruses. Systematic surveillance of influenza viruses in pigs is essential for early 
warning and preparedness for the next potential pandemic. Here, we report on an influenza virus 
surveillance of pigs from 2011 to 2018 in China, and identify a recently emerged genotype 4 (G4) 
reassortant Eurasian-avian (EA) H1N1 virus, which bears 2009 pandemic (pdm/09) and triple-
reassortant (TR)-derived internal genes and has been predominant in swine populations since 
2016. Similar to pdm/09 virus, G4 viruses bind to human-type receptors, produce much higher 
progeny virus in human airway epithelial cells, and show efficient infectivity and aerosol 
transmission in ferrets. Moreover, low antigenic cross-reactivity of human influenza vaccine 
strains with G4 reassortant EA H1N1 virus indicates that pre-existing population immunity does 
not provide protection against G4 viruses. Further serological surveillance among occupational 
exposure population showed that 10.4% (35/338) of swine workers were positive for G4 EA H1N1 
virus, especially for participants of 18-35 years old who had 20.5% (9/44) seropositive rates, 
indicating that the predominant G4 EA H1N1 virus has acquired increased human infectivity. 
Such infectivity greatly enhances the opportunity for virus adaptation in humans, and raises 
concerns for the possible generation of pandemic viruses. 
Significance Statement 
Pigs are intermediate hosts for the generation of pandemic influenza virus. Thus, systematic 
surveillance of influenza viruses in pigs is a key measure for pre-warning the emergence of the 
next pandemic influenza. Here, we identified a triple reassortant EA H1N1 virus possessing 
pdm/09 and TR-derived internal genes, termed as G4 genotype, which has become predominant 
in swine populations since 2016. Similar to pdm/09 virus, G4 viruses have all the essential 
hallmarks of a candidate pandemic virus. Of concern is that swine workers show elevated 
seroprevalence for G4 virus. Controlling the prevailing G4 EA H1N1 viruses in pigs and close 








Influenza A virus (IAV) is a global pathogen of humans and a wide range of mammalian and 
avian species. Reassortment of influenza viruses is a major mechanism to generate progeny 
viruses with novel antigenic and biological characteristics, which can cause catastrophic human 
epidemics and pandemics. Historically, pandemic influenza A viruses from 1957, 1968 and 2009 
are all reassortants derived from human and animal influenza viruses (1, 2). Pigs, being 
susceptible to avian, swine and human influenza A viruses, are regarded as “mixing vessels” in 
the generation of influenza viruses with pandemic potential (3-5). The emergence of the pdm/09 
H1N1 virus vividly illustrates the importance of pigs in new outbreaks (6-8). Therefore, continuous 
surveillance of swine influenza viruses (SIVs) in pigs and assessment of their zoonotic potential 
are essential for the preparedness of human pandemics. 
China has arguably the most complex SIVs ecosystem with classical swine (CS) lineage, North 
American triple-reassortant (TR) lineage, and Eurasian-avian (EA) lineage SIVs co-circulating in 
pigs (9). EA H1N1 SIVs are found in 2001, and gradually become the dominant lineage in China 
(9-11). However, after 2009, the 2009 pandemic (pdm/09) H1N1 virus in humans has spread 
back into pig herds around the world (12, 13). Subsequently, reassortants between the swine EA 
H1N1 virus and human pdm/09 H1N1 virus have been sporadically detected in pigs in China and 





However, the current prevalence and biological properties of these emergent EA reassortants 
and their infectivity in human population are unknown. 
In this study, we performed an extensive SIVs surveillance program in 10 provinces with high 
density pig populations between 2011 and 2018. We identified a predominant emergent EA 
reassortant G4 virus in pigs, which has pdm/09 and TR-derived internal genes and shows 
efficient infectivity and transmissibility in the ferret model. Serological surveillance among swine 
workers and general population showed that G4 EA H1N1 viruses have acquired increased 







EA H1N1 Viruses Exhibit Increased Genetic Diversity Since 2013. To investigate the 
epidemiological status of SIVs, from 2011 to 2018, we performed active surveillance and 
collected a total of 29,918 nasal swab samples from normal pigs in slaughterhouses in 10 
provinces with high density pig populations (SI Appendix, Fig. S1). We isolated 136 influenza 
viruses from these samples, with an isolation rate of 0.45% (SI Appendix, Table S1). In the same 
period, 1,016 nasal swabs or lung samples were collected from pigs showing respiratory 
symptoms in our school’s veterinary teaching hospital, of which, 43 were positive for influenza 
virus at an isolation rate of 4.23% (SI Appendix, Table S1). Based on sequence analysis of the 
hemagglutinin (HA) and neuraminidase (NA) genes of the combined 179 SIVs, they were 
identified as EA H1N1 (n = 165), pdm/09 H1N1 (n = 7), CS H1N1 (n = 1), H3N2 (n = 4), and 
H9N2 (n = 2) viruses (SI Appendix, Table S1), indicating that EA H1N1 is the predominant 
subtype virus circulating in pig populations in China. Among them, only EA H1N1 virus was 
isolated every year, while other SIVs such as CS H1N1 and H3N2 were only found in certain 
years. Seven pdm/09 H1N1 viruses were only found in 2011, indicating that pdm/09 H1N1 virus 
was not maintained in pigs even though it was generated from pigs (2). All 43 viruses isolated 
from diseased pigs were of EA H1N1 subtype. It is noted that the mean virus isolation rates from 
diseased pigs increased annually from 1.40% in 2011 to 8.21% in 2018, with a sharp increase 
from 2014 (SI Appendix, Fig. S2), indicating that EA H1N1 viruses are a growing problem in pig 
farms.  
To understand the phylogenetic evolution of the prevailing EA H1N1 viruses, a total of 77 viruses 
were selected for full genome sequencing on the basis of isolation time and location, with at least 
one strain sequenced per province (SI Appendix, Table S2). The whole genomes of 77 viruses 
were analyzed along with all available EA H1N1 sequences from both swine and human viruses 
in mainland China from 2011 to 2018. Based on the unified swine H1 HA nomenclature system 
(24), the HA genes of all the EA H1N1 viruses isolated in the study belonged to clade 1C.2.3 (SI 
Appendix, Fig.S3). Viruses isolated during 2011-2013 had relative short evolutionary branches, 
However, long branches leading to several lineages were found in viruses isolated after 2013 
(Fig. 1A). NA genes had a similar genetic evolution pattern (SI Appendix, Fig. S3). Notably, also 
after 2013, the six internal genes exhibited distinct diversity with multiple origins from original EA, 
pdm/09, Avian, and TR lineages (SI Appendix, Fig. S3). These results suggest that the genomes 
of EA H1N1 SIVs have undergone increased diversity since 2013. 
Genotype 4 Reassortant EA H1N1 Viruses Have Been Predominant Since 2016. To show 
viral evolution, we conducted molecular clock phylogenic analysis and genotype characterization 
(Fig. 2A and SI Appendix, Fig. S4). Based on lineage classification, six genotypes of G1 ~ G6 
were found in EA H1N1 viruses from 2011 to 2018 (Fig. 2B). The virus with all eight genes from 
the “pure” EA H1N1 lineage was designated as G1. G1 viruses were predominately circulating in 
both southern and northern China from 2011 to 2013 (SI Appendix, Fig. S5). However, 
prototypical EA H1N1 viruses had largely disappeared since 2014 (Fig. 2B, and SI Appendix, Fig. 
S5). G2, G3 and G6 reassortant EA viruses appeared transiently during 2011-2015. In 2013, two 





possess the HA, NA and matrix (M) genes from the original EA H1N1 lineage, the viral 
ribonucleoprotein (vRNP) genes from the pdm/09 lineage, and the nonstructural (NS) gene from 
the TR lineage. G5 virus was detected continuously from 2013 to 2017, but it declined since 2015 
and was not found in 2018 (Fig. 2B). Similar to the G5, G4 was also a triple reassortant except its 
M gene was derived from pdm/09 lineage. G4 virus showed a sharp increase since 2016, and is 
the predominant genotype in circulation in pigs detected across at least 10 provinces (Fig. 2B, 
and SI Appendix, Fig. S5). 
To assess the zoonotic potential of the G4 reassortant EA viruses, four representative G4 viruses 
(A/swine/Shandong/1207/2016 [SW/SD/1207/16], A/swine/Hebei/0116/2017 [SW/HB/0116/17], 
A/swine/Henan/SN13/2018 [SW/HN/SN13/18], and A/swine/Jiangsu/J004/2018 [SW/JS/J004/18]) 
were selected for further biological characterization. Two G1 strains (A/swine/Henan/08/2011 
[SW/HN/08/11], and A/swine/Hebei/T37/2013 [SW/HB/T37/13]) and a pdm/09 H1N1 virus 
A/California/04/09 (CA04) were also selected for comparison. 
G4 EA H1N1 Viruses Preferentially Bind Human-like SAα2,6Gal Receptor. The binding 
preference of HA to host SAα2,6Gal receptor is a critical determinant for cross-species 
transmission of influenza A viruses to humans (25, 26). We determined the binding affinity of EA 
H1N1 viruses to SAα2,3Gal and SAα2,6Gal sialylglycopolymers. Like pdm/09 virus CA04, all the 
four G4 EA H1N1 viruses as well as the two G1 viruses bound SAα2,6Gal receptors with high 
affinity but bound poorly to SAα2,3Gal receptors (SI Appendix, Fig. S6A). Furthermore, all the EA 
H1N1 viruses were found to bind to human tracheal epithelial lining to a similar extent as CA04 
pdm/09 H1N1 virus, but control avian H5N1 virus showed no binding (SI Appendix, Fig. S6B). 
Thus, these results demonstrate that G4 EA H1N1 viruses preferentially bind human-like 
SAα2,6Gal receptor, a key prerequisite for infecting human cells. 
G4 EA H1N1 Viruses Replicate Efficiently in Human Airway Epithelial Cells. Next, we 
assessed the replication of G4 viruses in normal human bronchial epithelial (NHBE) cells and 
alveolar epithelial (A549) cells, the major target cells in human influenza virus infection. In NHBE 
cells, G4 and pdm/09 viruses replicated to similar levels at each time point, and both of them 
produced more viable progeny viruses during 36 ~ 60 h post infection (pi) than did G1 viruses (P 
< 0.05 or P < 0.01, ANOVA) (SI Appendix, Fig. S7A). 
Infection of human A549 cells with G4 viruses gave similar progeny results. G4 and pdm/09 
viruses produced more infectious virus than that of G1 viruses from 24 h to 60 h pi (P < 0.05 or P 
< 0.01, ANOVA), reaching highest titers of 107.75 and 107.5 median tissue culture infective dose 
(TCID50)/ml, respectively. In contrast, G1 viruses showed peak titers of 106.5 TCID50/ml (SI 
Appendix, Fig. S7B). Collectively, G4 EA reassortant viruses replicate efficiently in human airway 
epithelial cells, similar to that of pdm/09 H1N1 virus. 
G4 EA H1N1 Viruses Exhibit Efficient Infectivity and Transmissibility in Ferrets. Ferrets 
have been widely used as an experimental model to study human infection and transmission of 
influenza virus (27). Here, three ferrets were infected intranasally (i.n.) with each virus at a dose 
of 106 TCID50 in a 1.0 ml volume. We found that G1 EA or pdm/09 viruses caused only mild 
clinical signs (SI Appendix, Table S4). Infection with G4 EA viruses, on the other hand, resulted in 
more severe clinical symptoms such as pyrexia, sneezing, wheezing, and coughing, with higher 
mean maximum weight loss ranging from 7.3% to 9.8% (SI Appendix, Table S4). Post-mortem 
and histopathology revealed that G4 virus-infected lungs had more severe lesions than G1 or 
pdm/09 virus-infected lungs, with pronounced multifocal areas of consolidation, hemorrhage, and 
edema and exhibited more severe peribronchiolitis and bronchopneumonia (SI Appendix, Fig. 
S8A). All four G4 viruses replicated to higher titers in the upper respiratory tract (nasal turbinate 
and trachea) of ferrets, which were similar to pdm/09 viruses and significantly higher than the two 
G1 viruses (P < 0.05 or P < 0.01, ANOVA), while no infectious virus was recovered from 
extrapulmonary tissues (SI Appendix, Fig. S8B). Overall, current G4 reassortant EA H1N1 viruses 
showed increased replication and pathogenicity in ferrets, indicating that G4 viruses are likely to 
cause more severe infection than G1 EA H1N1 viruses in humans. 
Efficient human-to-human transmission is a critical feature of pandemic influenza viruses. To 
assess the transmissibility of G4 viruses, we performed direct-contact (DC) and respiratory-





H1N1 virus efficiently transmitted to all ferrets by DC and RD (Fig. 3). All four G4 viruses were 
transmitted to all DC animals. Importantly, three of four G4 viruses, SW/SD/1207/16, 
SW/HN/SN13/18 and SW/JS/J004/18, were transmitted to all three RD-ferrets. The remaining G4 
virus SW/HB/0116/17 was transmitted to 1 of 3 RD-ferrets (Fig. 3). By contrast, with G1 viruses, 
neither virus transmission in DC or RD groups (Fig. 3), nor seroconversion at 14 dpi was detected 
in all recipient ferrets (SI Appendix, Table S4). Thus, there is compelling evidence to show that 
current predominant G4 reassortant EA H1N1 viruses are highly transmissible by DC and RD 
among ferrets, suggesting their capacity to readily infect humans. 
G4 EA H1N1 Viruses Exhibit Low Antigenic Cross-Reactivity with Human Influenza 
Vaccine Strains. Pre-existing immunity can protect humans from related influenza viruses, but 
antigenic drift can decrease such protection in a population. Antigenic change is mainly due to 
variation of the HA gene. In this study, we found that the HA gene of EA H1N1 viruses isolated 
after 2013 including G4 viruses formed an independent phylogenetic group. To determine the 
extent of antigenic drift of G4 viruses, 14 representative EA H1N1 viruses (ten G4 and four G1 
viruses) were selected based on their HA phylogenic topology for antigenicity test.  
A panel of ferret sera were used for hemagglutination inhibition (HI) assays, including sera 
against pdm/09 H1N1 virus A/Michigan/45/2015 from the current H1N1 human influenza vaccine 
lineage, G1 EA H1N1 viruses SW/HN/08/11 and SW/HB/T37/13, and G4 EA H1N1 viruses 
SW/SD/1207/16 and SW/HN/SN13/18. On the basis of reactivity levels in HI assays, EA viruses 
could be classified into antigenic group A and B (Fig. 1B and SI Appendix, Table S5). The original 
G1 EA viruses were in antigenic group A, while G4 viruses belonged to antigenic group B. The 
cross-reactive titers between the two antigenic groups were 8-64 fold lower than those of 
homologous reactions. Antisera against pdm/09 H1N1 viruses (A/Michigan/45/2015) cross-
reacted with antigenic group A viruses (titers 1:160-320) but reacted poorly with antigenic group B 
strains (titers < 40) (SI Appendix, Table S5). Further analysis showed that several amino acid 
differences in the HA antigenic sites among G1 and G4 EA H1N1 viruses, including 135 (H1 
numbering) and 222 in Ca2, and 185 in Sb (SI Appendix, Table S6). However, which amino acid 
contributes to the observed antigenic change need to be determined in future. Thus, predominant 
G4 reassortant EA H1N1 viruses are antigenically distinct from the earlier G1 EA and pdm/09 
H1N1 viruses. 
To assess cross-protection of human seasonal influenza vaccine against G4 EA viruses, HI 
assays were performed with 20 serum samples collected from 4-year-old children vaccinated with 
trivalent vaccines (pdm/09 H1N1+ H3N2 + B/Victoria). All serum samples were reactive (titers ≥ 
1:40) to pdm/09 H1N1 and H3N2 viruses (Fig. 1C). However, none of the serum samples cross-
reacted with the G4 or even the G1 EA H1N1 virus (Fig. 1C). Collectively, predominant G4 
reassortant EA viruses are antigenically distinct from current human influenza vaccine strains, 
indicating that pre-existing immunity derived from the present human seasonal influenza vaccines 
cannot provide protection against G4 viruses.  
G4 EA H1N1 Viruses Showed Increased Infection Rate in Humans Evidenced by 
Seroprevalence. To determine whether the G4 reassortant EA H1N1 virus can infect across 
species from swine to humans, serological surveillance was conducted to detect prevalence of 
virus exposure in swine production workers. From 2016 to 2018, a total of 338 serum samples 
were collected from swine workers in 15 farms. Serum samples (n = 230) from ordinary 
households were also collected as a population comparison group. G4 EA virus SW/SD/1207/16, 
which belonged to antigenic group B, was used as virus antigen in HI assays. To control for 
interference of H1N1 antibody against pdm/09 and earlier G1 EA viruses, pdm/09 virus 
A/Michigan/45/2015 and G1 EA virus SW/HN/08/11 were included as viral antigens. 
Disconcertingly, 10.4% (35/338) of swine workers and 4.4% (10/230) of general population were 
positive (titers ≥ 1:40) for G4 virus SW/SD/1207/16. In the multivariable analysis, after adjusting 
for confounders, swine workers had an increased odds ratio [aOR = 2.60, 95% CI (1.24-5.45), P 
= 0.012] compared with the general population group. After controlling for possible cross-
reactivity with pdm/09 virus the odds ratio remained elevated [aOR = 2.25, 95% CI (1.05-4.83), P 
= 0.038] (Table 1). It is noted that swine workers in 4 of 15 farms were more than 15% 





(22/338) of swine workers and 2.2% (5/230) of the general population were positive for G1 virus 
SW/HN/08/11, with no statistically significant difference (P = 0.068) between the two groups after 
controlling for possible cross-reactivity with pdm/09 virus (Table 1). In addition, swine workers 
group and general population were 38.8% (131/338) and 31.7% (73/230) seropositive 
respectively for pdm/09 H1N1 virus A/Michigan/45/2015 (P = 0.082). These results demonstrate 
that the newly prevalent G4 reassortant EA H1N1 viruses in pigs are more infectious to humans 
than their predecessors of G1 viruses. 
We further investigated the association of sera collection year, age or gender with seroprevalence 
of G4 reassortant EA H1N1 virus. In the swine workers group, the seropositive rates of G4 EA 
H1N1 virus were 6.7%, 11.7%, and 11.7% from 2016, 2017 and 2018, respectively (SI Appendix, 
Table S8). It is noteworthy that participants 18-35 years of age had 20.5% (9/44) seropositive rate 
against G4 EA H1N1 virus SW/SD/1207/16, which had an increased odds ratio [OR=3.2, 95% CI 
(1.3-7.7), P < 0.01] compared with other age groups (SI Appendix, Table S8). For gender factor, 
there were no statistically significant difference in the seroprevalence of any virus tested 
according to sex were observed (P > 0.05). These results indicate that young adult swine workers 





Pigs can independently facilitate the genesis of a human pandemic IAV strain (2, 7). Thus, 
continual systematic monitoring and assessing potential risks of emerging influenza viruses in 
pigs are necessary for early warning of future pandemics (28). In this study, based on extensive 
influenza A virus surveillance in pigs from 2011 to 2018, we identified and characterized a 
predominant triple reassortant SIVs (G4 genotype) derived from the reassortment of previous EA, 
pdm/09, and TR viruses. G4 H1N1 viruses are able to bind human-like SAα2,6Gal-linked 
receptor, replicate well in human airway epithelial cells, and transmit by aerosol among ferrets; 
they are antigenically distinct from pdm/09 H1N1 viruses. Of concern is that serological 
surveillance indicates the G4 reassortant EA H1N1 virus exhibits elevated infectivity in humans, 
especially for swine-exposed younger adults, which increases the opportunity for virus adaptation 
in humans. 
EA H1N1 virus has been circulating in pigs in Europe and Asia for decades (29-31). In 2001, EA 
virus was found in Hong Kong and gradually became dominant in mainland China (9-11). Here, 
we also found that the “pure” EA H1N1 viruses of G1 were predominant in swine population from 
2011 to 2013. However, since 2014, G4 and G5 reassortant EA H1N1 viruses gradually replaced 
the prototypical EA H1N1 viruses, and currently G4 viruses are the single predominant genotype 
circulating in China. Surveillance from farmed pigs with respiratory symptoms had shown that its 
isolation rate increased sharply after 2014, and increased year by year (SI Appendix, Fig. S2). 
Others have also reported on the infection of G4-like reassortant EA H1N1 viruses in farmed pigs 
(16, 18). A typical feature of G4 virus is that vRNP and M genes originate from pdm/09 virus and 
NS gene is from TR virus, indicating that this gene constellation has a distinct competitive 
advantage in pigs. All these evidences indicate that G4 EA H1N1 virus is a growing problem in 
pig farms, and the widespread circulation of G4 viruses in pigs inevitably increases their exposure 
to humans. So far, a total of 5 human cases of EA-like swine influenza virus infection had been 
reported in China (21-23, 32, 33). The first three cases were children under 3 years old, but the 
latest two cases reported in 2016 and 2019 were of a 46 and a 9 year old, respectively. Genetic 
analysis indicated that the latter two cases were caused by G4-like EA H1N1 virus. 
Epidemiological survey found that the two patients had neighbors who reared pigs, suggesting 
that G4 EA virus could transmit from swine to human, and lead to severe infection and even 
death (22, 23). Thus, it is necessary to strengthen the surveillance effort of G4 EA viruses among 
swine and human populations.  
Pandemic occurs when an IAV with novel HA surface antigen becomes readily able to undertake 
human to human transmission. G4 genotype of reassortant SIVs, identified in the present study, 





antigenicity from current human influenza viruses. Similar to pdm/09 virus, G4 virus preferentially 
binds human-like SAα2,6Gal receptor and effectively transmits in the ferret model. The G4 virus 
also shows increased pathogenicity based on the present ferret study and other reports in mice 
(18, 34, 35). A limited serological investigation found that general population who had little 
opportunity to contact pigs, lacked antibodies against G4 virus, but swine-exposed adult 
population showed elevated seroprevalence (10.4%, 35/338), which further supports our 
hypothesis of G4 virus transmission from pigs to human. It is of concern that human infection of 
G4 virus will further human adaptation and increase the risk of a human pandemic. 
In summary, G4 EA H1N1 viruses possess all the essential hallmarks of highly adapted to infect 
humans. Controlling the prevailing G4 EA H1N1 viruses in pigs and close monitoring of swine 
working populations should be promptly implemented. 
 
 
Materials and Methods 
 
All animal research was approved by the Beijing Association for Science and Technology 
(approval ID SYXK, Beijing, 2007–0023) and performed in compliance with the Beijing Laboratory 
Animal Welfare and Ethics guidelines, as issued by the Beijing Administration Committee of 
Laboratory Animals, and in accordance with the China Agricultural University (CAU) Institutional 
Animal Care and Use Committee guidelines (ID:SKLAB-B-2010-003) approved by the Animal 
Welfare Committee of CAU. All experiments with live viruses were performed in biosafety level 2 
facilities in CAU.  
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Figure 1. Phylogenetic relationship of HA gene and antigenic characterization of EA H1N1 SIVs 
in China from 2011 to 2018. (A) Phylogenetic tree of HA gene. Phylogenetic tree was estimated 
using genetic distances calculated by maximum likelihood under the GTRGAMMA + I model. 
SIVs isolated in this study were green, sequences of viruses with name in black were 
downloaded from databases. Scale bar is in units of nucleotide substitutions per site. Node labels 
represent bootstrap values. Viruses labeled with a red triangle were selected for antiserum 
generation. A full detailed HA gene tree with the consistent topology is shown in SI Appendix, Fig. 
S3. (B) Antigenic map based on the HI assay data. Open squares and filled circles represent the 
positions of antisera and viruses, respectively. Clusters were identified by a k-means clustering 
algorithm. Strains belonging to the same antigenic cluster are encircled in an oval. The vertical 
and horizontal axes both represent antigenic distance. The spacing between grid lines is 1 unit of 
antigenic distance, corresponding to a twofold dilution of antiserum in the HI assay. Details of the 
HI assay data are shown in SI Appendix, Table S5. (C) Antigenic analysis of EA H1N1 and 
human influenza vaccine strains. Twenty serum samples, collected from 4-year-old children 
vaccinated with trivalent vaccines [A/Michigan/45/2015 (pdm/09 H1N1) + A/Singapore/INFIMH-
16-0019/2016 (H3N2) + B/Colorado/06/2017 (B/Victoria)], were subjected to HI assays. pdm/09 
H1N1 virus A/Michigan/45/2015, human H3N2 virus A/Singapore/INFIMH-16-0019/2016, G1 EA 
H1N1 virus SW/HN/08/11, and G4 EA H1N1 virus SW/SD/1207/16 were used as antigens. HI 








Figure 2. Phylogenetic analysis of EA H1N1 SIVs in China from 2011 to 2018. (A) Phylogeny and 
divergence time of the HA gene and genotype evolution of EA H1N1 SIVs. The phylogenetic tree 
of HA gene was generated by Bayesian Markov Chain Monte Carlo framework, using the GTR 
substitution model with gamma-distributed among site rate heterogeneity and a ‘strict molecular 
clock’ model. Colored boxes show the lineage classification of each gene segment of EA H1N1 
viruses. Purple node bars represent 95% credible intervals of lineage divergence times. A 
detailed phylogenetic tree including sequence names is shown in SI Appendix, Fig. S4. (B) 








Figure 3. Horizontal transmission of EA H1N1 viruses between ferrets. Groups of three ferrets 
were inoculated i.n. with 106 TCID50 of indicated viruses. The next day, infected animals were 
individually cohoused with an uninfected DC ferret; an uninfected RD contact animal was also 
housed in a wire frame cage adjacent to the infected ferret. Nasal washes for virus shedding 
detection were collected every other day from all animals from day 2 of the initial infection. Each 







Table 1. Seropositive rate of influenza virus in swine workers (SW) and common household 
population (CHP) 
 
 Univariable analysis  Multivariable regression analysis 
 SW (n = 338) CHP (n = 230) P value  aOR (95% CI)  Model 
Strain (Genotype) No. Pos % Pos No. Pos % Pos Chi2 SW versus CHP P value covariates 





Controls for possible cross-reactivity 
with pdm/09 H1N1 
      2.60 (0.93-7.23) 0.068 
SW/SD/1207/16 (G4 EA H1N1) 35 10.4 10 4.4 0.009  2.60 (1.24-5.45) 0.012 
Controls for possible cross-reactivity 
with pdm/09 H1N1 
      2.25 (1.05-4.83) 0.038 
A/Michigan/45/2015 (pdm/09 H1N1) 131 38.8 73 31.7 0.087  1.38 (0.96-1.99) 0.082  
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Virus Isolation and Identification. From January 2011 to April 2018, influenza surveillance in pigs 
was carried out in 10 provinces of China (Anhui, Beijing, Hebei, Heilongjiang, Henan, Jiangsu, Jilin, 
Liaoning, Shandong, and Tianjin). A total of 29,918 nasal swabs were collected from slaughtered 
pigs at abattoirs and a total of 1,016 nasal swabs or lung tissues were collected from farmed pigs 
with signs of respiratory disease. For virus isolation, nasal swabs were taken and placed in 1.0 ml 
transmission medium [50% (vol/vol) glycerol in PBS] containing antibiotics, as previously described 
(1). Lungs were homogenized in PBS containing antibiotics. All samples were individually inocu-
lated into both embryonated chicken eggs and MDCK cells for virus isolation. Allantoic fluid and 
culture supernatants were harvested and tested for HA activity. HI assays were performed using 
antisera against the H1, H3, H5 and H9 subtypes of influenza viruses. Viral RNA was extracted by 
using the QIAamp Viral RNA Minikit (Qiagen), and standard RT-PCR was performed with segment-
specific primers, using the One Step RT-PCR Kit (Qiagen). The HA and NA lineage of the viruses 
were determined by direct sequencing of the PCR products. Samples positive for SIVs were stored 
as stock at −80°C until use. 
Genomic Sequencing. Based on HA and NA gene sequences, a total of 77 viruses belonging to 
EA H1N1 lineage were selected for full genome sequencing on the basis of isolation time and 
location. At least one strain was sequenced per province. Whole genomic DNA was sequenced by 
Sanger sequencing on an ABI 3730 genetic analyzer (Applied Bio-systems). All nucleotide se-
quences of segments of the 77 influenza virus isolates detected in this study have been deposited 
in GenBank (Table S3). 
Phylogenetic Analyses. RAxML was used to construct maximum likelihood phylogenies for each 
segment (2), via CIPRES Science Gateway (3). 1,000 bootstrap replicates were run, and GTR-
GAMMA + I was used as the nucleotide substitution model. Each gene was classified to an evolu-
tionary lineage and/or phylogenetic clade (4, 5). Phylogenetic relationship of HA gene sequenced 
of SIVs was inferred with BEAST version 1.10.4 (6), using a molecular clock that places a timescale 
on virus evolution. Phylogeny was estimated within a Bayesian Markov Chain Monte Carlo (MCMC) 
framework, using the GTR substitution model with gamma-distributed among site rate heterogene-
ity and a ‘strict clock’ model. For the analysis employing Bayesian MCMC sampling, a chain length 
of at least 40 million steps was used with a 10% ‘burn-in’ removed. At least two independent runs 
of the chain were performed and compared to ensure adequate sampling. 
Receptor Binding Assays. α-2,6 glycans (6’SLN: Neu5Acα2-6Galβ1-4GlcNAcβ-SpNH-LC-LC-bi-
otin) and α-2,3 glycans (3’SLN: Neu5Acα2-3Galβ1-4GlcNAcβ-SpNH-LC-LC-biotin) were kindly 
provided by the Consortium for Functional Glycomics (Scripps Research Institute, Department of 
Molecular Biology, La Jolla, CA). Receptor-binding specificity was determined by a solid-phase 
direct binding assay as previously described (7). Briefly, serial dilutions (0.16 μg/ml, 0.32 μg/ml, 
0.63 μg/ml, 1.25 μg/ml, 2.5 μg/ml, 5 μg/ml, 10 μg/ml, and 20 μg/ml) of biotinylated glycans 3’SLN 
and 6’SLN were prepared in PBS, and 100μl was added to the wells of the 96-well microtiter plates 
(Polystyrene Universal-Bind Microplate; Corning) and allowed to attach overnight at 4°C. The plates 
were then irradiated with 254 nm ultraviolet light for 2 min. After removal of the glycopolymer solu-
tion, the plates were blocked with 0.1 ml of PBS containing 2% bovine serum albumin (BSA) at 
room temperature for 1 h. After washing with ice-cold PBS containing 0.1% Tween 20 (PBST), the 
plates were incubated in a solution containing influenza virus (64 HA units in PBST) at 4°C for 12 
h. After washing with PBST, chicken antisera against SW/SD/1207/16 (H1N1), CA04(H1N1) or 
A/Anhui/01/2005 (AH/05-H5N1) virus was added to each well and the plates were incubated at 4°C 
for 2 h. The wells were then washed with ice-cold PBST and incubated with HRP-linked goat-anti-
chicken antibody (Sigma-Aldrich) for 2 h at 4°C. After washing with ice-cold PBST, the plates were 
incubated with O-phenylenediamine in PBS containing 0.01% H2O2 for 10 min at room temperature. 
The reaction was stopped with 0.05 ml of 1 M H2SO4 and the absorbance was determined at 450 
nm. 
Virus Binding to Human Tracheal Tissues. Paraffin-embedded 5 μm sections of normal human 
tracheal and lung tissues were deparaffinized in xylene and rehydrated by alcohol. Sections were 





at 4°C overnight. After four washes in ice-cold PBS, the sections were incubated with mouse mon-
oclonal antibody specific for influenza nucleoprotein (NP; Abcam, Cambridge, United Kingdom) for 
3 h at 4°C. Antibody binding was detected by FITC-labeled goat anti-mouse IgG (Abcam) incubated 
for 2 h at room temperature. The samples were examined by confocal laser scanning microscopy 
(Leica Microsystems).  
Infection of Human Airway Epithelial Cells. Primary NHBE cells were obtained from ATCC. Cells 
of passage 2 were grown on membrane supports (12-mm Transwell-Clear Insert, Corning) at the 
air-liquid interface in serum-free and hormone- and growth factor-supplemented medium as de-
scribed (8). Fully differentiated 4 to 8-week-old cultures were used for all experiments. The apical 
surfaces of the cultures were washed 5 times to remove accumulated mucins before inoculation 
with virus at a multiplicity of infection (MOI) of 0.001. The inoculum was removed after 1 h of incu-
bation at 33°C. No trypsin was added to the cultures because previous studies using similar cul-
tures demonstrated efficient proteolytic activation of influenza viruses by endogenous proteases (9, 
10). Supernatants were sampled at 12, 24, 36, 48, 60 and 72 hpi, and titrated by inoculating MDCK 
cells. 
A549 cells were cultivated in Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen) supple-
mented with 10% fetal bovine serum, 100 units/ml of penicillin and 100 µg/ml of streptomycin. Mul-
tistep replication kinetics were determined by infecting A549 cells at a MOI of 0.001. After 1 h of 
incubation at 37°C, the cells were washed twice and further incubated in serum-free DMEM con-
taining 0.5 μg/ml TPCK-trypsin. Supernatants were sampled at 12, 24, 36, 48, 60, and 72 hpi, and 
titrated by inoculating MDCK cells. Each experiment was performed in triplicate. 
Ferret Pathogenesis and Transmission Experiments. All 6-month-old male Angora ferrets (An-
gora LTD), seronegative for currently circulating influenza viruses (H1, H3, H5, H7, and H9). 
Groups of three ferrets were each anesthetized with ketamine (20 mg/kg) and xylazine (1 mg/kg) 
and i.n. inoculated with 106 TCID50 of test virus in a 1-ml volume. The animals were subsequently 
euthanized on 3 day pi, and nasal turbinate, trachea, lung, spleen, kidney and brain samples were 
collected for virus titration. Lung tissues were also used for histology. 
In the transmission experiment, groups of three animals were anesthetized and inoculated i.n. with 
106 TCID50 of virus. The next day, the three inoculated animals were individually paired by cohous-
ing with a DC ferret; a RD-contact animal was also housed in a wire frame cage adjacent to the 
infected ferret. The infected and RD-contact ferrets were 5 cm apart. To monitor virus shedding, 
nasal washes were collected from all animals every other day over 12 days and titrated for virus in 
MDCK cells. Sera were collected from both inoculated and contacted animals at 14 dpi. Serocon-
version was analyzed by HI assay. Clinical signs, temperature and body weight were recorded daily 
in all ferrets. 
Antigenic Analyses. Antigenic characteristics of EA H1N1 viruses were compared using a HI as-
say with ferret antisera raised against representative viruses. Ferret antisera raised against 
SW/HN/08/11 (G1), SW/HB/T37/13 (G1), SW/SD/1207/16 (G4) and SW/HN/SN13/18 (G4) viruses 
were produced in our laboratory, hyperimmune goat serum against pdm/09 H1N1 A/Michi-
gan/45/2015 were provided by Chinese National Influenza Center. HI tests were performed in ac-
cordance with WHO guidelines. All HI assays were performed in duplicates. Analysis of antigenic 
properties was performed using the antigenic cartography methods described previously (11). The 
antigen cartography of the viruses was constructed using Antigenic Cartography software 
(http://www.antigenic-cartography.org/). Clusters were identified in the antigenic map by a k-means 
clustering algorithm, using average weighting, and k = 3. 
HI assays were also used to determine the antigenic cross-reactivity of EA H1N1 viruses with pre-
vailing human influenza vaccine strains. Positive human sera were collected from twenty 4-year-
old children at 30 days after two immunizations with influenza trivalent vaccines (A/Michi-
gan/45/2015 + A/Singapore/INFIMH-16-0019/2016 + B/Colorado/06/2017) by Chinese National In-
fluenza Center. HI antigens of A/Michigan/45/2015 (pdm/09 H1N1), A/Singapore/ INFIMH-16-
0019/2016 (human seasonal H3N2) were provided by Chinese National Influenza Center. HI tests 





Serological Survey of G1, G4 EA and pdm/09 H1N1 Viruses Infection in Humans. From 2016 
to 2018, a total of 338 serum samples were collected from swine workers in 15 pig farms. Farms 
were in two main clusters in Hebei and Shandong province, both regions with high density pig 
populations. At the same time, 230 blood samples were obtained from ordinary household popula-
tions to form the population comparison group. General population samples were frequency-
matched to swine workers on age group, geographic region, calendar month of blood sample and 
gender. HI tests were performed in accordance with WHO guidelines. G1 EA virus SW/HN/08/11, 
G4 EA virus SW/SD/1207/16, and pdm/09 H1N1 virus A/Michigan/45/2015 were used as antigens. 
1% turkey erythrocytes were used in HI assays. Based on the WHO guideline for vaccine evaluation, 
the HI antibody titers ≥ 40 were considered as positive. 
Statistical Methods. Experimental groups were statistically compared by ANOVA. P < 0.05 was 
considered to indicate a statistically significant difference. 
In dichotomous outcome examinations, the Pearson's chi-square test or Fisher's exact test was 
used to compare differences between groups. In multivariable logistic regression analyses, poten-
tial confounding effects of gender, age and collection time were examined. As there was strong 
evidence that G1 or G4 virus seropositivity in humans were associated with seropositivity to pdm/09 
H1N1 (P < 0.001), pdm/09 H1N1 was also forced into regression models to account for possible 
cross-reactivity. The magnitude of association between the variables and seropositivity was ex-
pressed as an OR with 95% CI. P < 0.05 was considered to indicate a statistically significant differ-








Fig. S1. Map showing pig density in China and geographic location of influenza surveillance in pigs 
from 2011 to 2018. The number of pigs in each province is the average number from 2014 to 2018; 
data were from the National Bureau of Statistics of China. Red triangle indicates province where 







Fig. S2. Isolation rate (%) of SIVs in the period of 2011–2018 from diseased pigs. From 2011 to 
2018, number of nasal swabs or lung samples collected from diseased pigs were 143, 162, 94, 141, 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. S3. Phylogenetic relationships of fully sequenced EA H1N1 SIVs in China in the period of 2011 
to 2018. Phylogenetic trees were estimated using genetic distances calculated by maximum likeli-
hood under the GTRGAMMA + I model. SIVs isolated in this study were colored according to the 
phylogenetic classification of each gene segment. Sequences of viruses with names in black were 
downloaded from public databases; human EA H1N1 viruses are indicated in purple. Scale bar is 







Fig. S4. Phylogeny and divergence time of the HA gene and genotype evolution of EA H1N1 SIVs. 
The phylogenetic tree of HA gene was generated by Bayesian MCMC framework, using the GTR 
substitution model with gamma-distributed among site rate heterogeneity and a ‘strict molecular 
clock’ model. Colored boxes show the lineage classification of each gene segment of EA H1N1 
viruses. Purple node bars represent 95% credible intervals of lineage divergence times. Viruses 
labeled with a red asterisk were selected for biological characterization. Viruses labeled with a red 


























































































































































































































Fig. S5. Geographic distribution of genotypes identified for 187 EA H1N1 viruses isolated in China 
from 2011 to 2018. The six genotypes of EA H1N1 viruses were mapped chronologically to show 







Fig. S6. Host receptor-binding affinity of influenza virus. (A) Strong binding affinity of G1 and G4 
viruses to α2,6-linked (red) but not to α2,3-linked (blue) sialic acid polymers. pdm/09 H1N1 virus 
(CA04) and an avian H5N1 virus (AH/05) that selectively bound SAα2,6Gal and SAα2,3Gal, re-
spectively, were used as controls. (B) Similar binding of G1, G4 and pdm/09 viruses to human 
respiratory tract. G4 and G1 EA H1N1, control avian H5N1 and human pdm/09 H1N1 viruses were 
used to incubate human tracheal sections and subsequently immunostained for influenza NP with 







Fig. S7. Viral growth properties in NHBE (A) and A549 (B) cells. Cells were infected with indicated 
viruses at MOI of 0.001 and incubated at 33°C (A) and 37°C (B), respectively. Supernatants were 
harvested at the indicated time points and the virus titers were determined in MDCK cells. Values 
are expressed as means ± standard deviations (SD) (n = 3). *, P < 0.05, **, P < 0.01, between G4 
or pdm/09 virus-infected cells and G1 virus-infected cells. 
  























































Fig. S8. Pathogenicity and replication of EA H1N1 SIVs in ferrets. (A) Gross and histopathological 
examination on the respiratory tracts of infected ferrets at 3 dpi. Representative gross (left) and 
corresponding histological (H&E staining) findings at low (middle) and high (right) magnification are 
presented. (B) Progeny virus production of influenza viruses in ferrets. Each ferret, in groups of 
three, was intranasally inoculated with 106 TCID50 of indicated virus. G4 or pdm/09 progeny virus 
titers were significantly higher than G1 titers in the upper respiratory tract (nasal and tracheal re-
gions) (*P < 0.05, **P < 0.01, ANOVA). The indicated tissues were collected at 3 dpi for virus 
titration. All values shown are means ± SD from three independent experiments for each sample. 



















CS H1N1 EA H1N1 pdm/09 H1N1 H3N2 H9N2 
2011 Slaughter houses 5,540 27 0.49  20 7   
 Veterinary hospital 143 2 1.40  2    
2012 Slaughter houses 4,960 23 0.46  21   2 
 Veterinary hospital 162 2 1.23  2    
2013 Slaughter houses 5,310 19 0.36  18  1  
 Veterinary hospital 94 1 1.06  1    
2014 Slaughter houses 2,913 12 0.41 1 11    
 Veterinary hospital 141 5 3.55  5    
2015 Slaughter houses 3,164 17 0.54  16  1  
 Veterinary hospital 128 7 5.47  7    
2016 Slaughter houses 2,156 9 0.42  9    
 Veterinary hospital 93 6 6.45  6    
2017 Slaughter houses 2,755 14 0.51  14    
 Veterinary hospital 121 9 7.44  9    
2018 Slaughter houses 3,120 15 0.48  13  2  
 Veterinary hospital 134 11 8.21  11    
2011-2018 Slaughter houses 29,918 136 0.45 1 122 7 4 2 







Table S2. Detailed information of EA H1N1 viruses isolated in this study 
Strain name Collection date Collection place PB2 PB1 PA HA NP NA M NS Genotype 
A/swine/Henan/201/2011 Jan-2011 Henan EA EA EA EA EA EA EA EA 1 
A/swine/Henan/202/2011 Jan-2011 Henan EA EA EA EA EA EA EA EA 1 
A/swine/Henan/97/2011 Jan-2011 Henan EA EA EA EA EA EA EA EA 1 
A/swine/Jiangsu/89/2011 Jan-2011 Jiangsu EA EA EA EA EA EA EA EA 1 
A/swine/Beijing/496/2011 Feb-2011 Beijing EA EA EA EA EA EA EA EA 1 
A/swine/Beijing/592/2011 Feb-2011 Beijing EA EA EA EA EA EA EA EA 1 
A/swine/Beijing/957/2011 Sep-2011 Beijing EA EA EA EA EA EA EA EA 1 
A/swine/Hebei/19/2011 Oct-2011 Hebei EA EA EA EA EA EA EA EA 1 
A/swine/Hebei/36/2011 Oct-2011 Hebei EA EA EA EA EA EA EA EA 1 
A/swine/Henan/08/2011 Oct-2011 Henan EA EA EA EA EA EA EA EA 1 
A/swine/Henan/15/2011 Oct-2011 Henan EA EA EA EA EA EA EA EA 1 
A/swine/Beijing/82/2011 Nov-2011 Beijing EA EA EA EA EA EA EA EA 1 
A/swine/Jilin/63/2011 Nov-2011 Jilin EA EA EA EA EA EA EA EA 1 
A/swine/Hebei/102/2011 Dec-2011 Hebei EA EA EA EA EA EA EA EA 1 
A/swine/Tianjin/137/2011 Dec-2011 Tianjin EA EA EA EA EA EA EA EA 1 
A/swine/Hebei/156/2012 Jan-2012 Hebei EA EA EA EA EA EA EA EA 1 
A/swine/Hebei/350/2012 Jan-2012 Hebei EA EA EA EA EA EA EA EA 1 
A/swine/Henan/08/2012 Feb-2012 Henan EA EA EA EA EA EA EA EA 1 
A/swine/Henan/20/2012 Feb-2012 Henan EA EA EA EA EA EA EA EA 1 
A/swine/Henan/458/2012 Feb-2012 Henan EA EA EA EA EA EA EA EA 1 
A/swine/Liaoning/408/2012 Feb-2012 Liaoning EA EA EA EA EA EA EA EA 1 
A/swine/Liaoning/458/2012 Feb-2012 Liaoning EA EA EA EA EA EA EA EA 1 
A/swine/Shandong/436/2012 Feb-2012 Shandong EA EA EA EA EA EA EA EA 1 
A/swine/Beijing/731/2012 Mar-2012 Beijing EA EA EA EA EA EA EA EA 1 
A/swine/Hebei/535/2012 Mar-2012 Hebei EA EA EA EA EA EA EA EA 1 
A/swine/Hebei/561/2012 Mar-2012 Hebei EA EA EA EA EA EA EA EA 1 
A/swine/Liaoning/590/2012 Mar-2012 Liaoning EA EA EA EA EA EA EA EA 1 
A/swine/Liaoning/896/2012 Mar-2012 Liaoning EA EA EA EA EA EA EA EA 1 
A/swine/Tianjin/741/2012 Mar-2012 Tianjin EA EA EA EA EA EA EA EA 1 
A/swine/Beijing/951/2012 Apr-2012 Beijing EA EA EA EA EA EA EA EA 1 
A/swine/Tianjin/960/2012 Apr-2012 Tianjin EA EA EA EA EA EA EA EA 1 
A/swine/Jilin/625/2013 Feb-2013 Jilin EA EA EA EA EA EA EA EA 1 
A/swine/Jilin/665/2013 Feb-2013 Jilin EA EA EA EA EA EA EA EA 1 
A/swine/Tianjin/525/2013 Feb-2013 Tianjin EA EA EA EA EA EA EA EA 1 
A/swine/Henan/727/2013 Mar-2013 Henan EA EA EA EA EA EA EA EA 1 
A/swine/Shandong/862/2013 Mar-2013 Shandong EA EA EA EA EA EA EA EA 1 
A/swine/Liaoning/950/2013 Apr-2013 Liaoning EA EA EA EA EA EA EA EA 1 
A/swine/Tianjin/9/2013 Oct-2013 Tianjin EA EA EA EA EA EA EA EA 1 
A/swine/Hebei/T37/2013 Nov-2013 Hebei EA EA EA EA EA EA EA EA 1 
A/swine/Shandong/39/2013 Nov-2013 Shandong EA EA EA EA EA EA EA EA 1 
A/swine/Liaoning/D66/2013 Dec-2013 Liaoning EA EA EA EA EA EA EA EA 1 
A/swine/Shandong/S113/2014 Nov-2014 Shandong pdm/09 pdm/09 pdm/09 EA pdm/09 EA EA TRIG 5 
A/swine/Shandong/S153/2014 Nov-2014 Shandong pdm/09 pdm/09 pdm/09 EA pdm/09 EA EA TRIG 5 
A/swine/Shandong/S269/2014 Nov-2014 Shandong pdm/09 pdm/09 pdm/09 EA pdm/09 EA EA TRIG 5 
A/swine/Shandong/S93/2014 Nov-2014 Shandong pdm/09 pdm/09 pdm/09 EA pdm/09 EA EA TRIG 5 
A/swine/Anhui/1227/2015 Dec-2015 Anhui pdm/09 pdm/09 Avian EA pdm/09 EA EA TRIG 6 
A/swine/Tianjin/158/2015 Dec-2015 Tianjin pdm/09 pdm/09 Avian EA pdm/09 EA EA TRIG 6 
A/swine/Tianjin/78/2015 Dec-2015 Tianjin pdm/09 pdm/09 Avian EA pdm/09 EA EA TRIG 6 
A/swine/Shandong/16/2016 Oct-2016 Shandong pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Shandong/36/2016 Oct-2016 Shandong pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Shandong/9/2016 Oct-2016 Shandong pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Jilin/21/2016 Nov-2016 Jilin pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Jilin/23/2016 Nov-2016 Jilin pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Jilin/29/2016 Nov-2016 Jilin pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Heilongjiang/1214/2016 Dec-2016 Heilongjiang pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Shandong/1203/2016 Dec-2016 Shandong pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Shandong/1207/2016 Dec-2016 Shandong pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Hebei/0113/2017 Jan-2017 Hebei pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Hebei/0116/2017 Jan-2017 Hebei pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Heilongjiang/0110/2017 Jan-2017 Heilongjiang pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Hebei/0221/2017 Feb-2017 Hebei pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Heilongjiang/0140/2017 Feb-2017 Heilongjiang pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Shandong/0334/2017 Mar-2017 Shandong pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Shandong/0336/2017 Mar-2017 Shandong pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Shandong/0337/2017 Mar-2017 Shandong pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Shandong/JM78/2017 Dec-2017 Shandong pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Shandong/LY142/2017 Dec-2017 Shandong pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Anhui/0202/2018 Feb-2018 Anhui pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Anhui/0203/2018 Feb-2018 Anhui pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Henan/SN10/2018 Feb-2018 Henan pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Henan/SN11/2018 Feb-2018 Henan pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Henan/SN12/2018 Feb-2018 Henan pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 





Table S2. Cont. 
Strain name Collection date Collection place PB2 PB1 PA HA NP NA M NS Genotype 
A/swine/Beijing/0301/2018 Mar-2018 Beijing pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Jiangsu/J004/2018 Mar-2018 Jiangsu pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 
A/swine/Jiangsu/J005/2018 Mar-2018 Jiangsu pdm/09 pdm/09 pdm/09 EA pdm/09 EA pdm/09 TRIG 4 







Table S3. Accession numbers for new sequences generated in this study 
Strain name PB2 PB1 PA HA NP NA M NS 
A/swine/Beijing/496/2011(H1N1) MN416330 MN416417 MN416517 MN416590 MN418734 MN416694 MN418814 MN418660 
A/swine/Beijing/592/2011(H1N1) MN416331 MN416418 MN416518 MN416591 MN418735 MN416695 MN418815 MN418661 
A/swine/Beijing/82/2011(H1N1) MN416333 MN416420 MN416520 MN416593 MN418737 MN416697 MN418817 MN418663 
A/swine/Beijing/957/2011(H1N1) MN416335 MN416422 MN416522 MN416595 MN418739 MN416699 MN418819 MN418665 
A/swine/Hebei/102/2011(H1N1) MN416339 MN416426 MN416526 MN416599 MN418743 MN416703 MN418823 MN418669 
A/swine/Hebei/19/2011(H1N1) MN416341 MN416428 MN416528 MN416601 MN418745 MN416705 MN418825 MN418671 
A/swine/Hebei/36/2011(H1N1) MN416343 MN416430 MN416530 MN416603 MN418747 MN416707 MN418827 MN418673 
A/swine/Henan/08/2011(H1N1) MN416350 MN416437 MN416537 MN416610 MN418754 MN416714 MN418834 MN418680 
A/swine/Henan/15/2011(H1N1) MN416352 MN416439 MN416539 MN416612 MN418756 MN416716 MN418836 MN418682 
A/swine/Henan/201/2011(H1N1) MN416354 MN416441 MN416541 MN416614 MN418758 MN416718 MN418838 MN418684 
A/swine/Henan/202/2011(H1N1) MN416355 MN416442 MN416542 MN416615 MN418759 MN416719 MN418839 MN418685 
A/swine/Henan/97/2011(H1N1) MN416358 MN416445 MN416545 MN416618 MN418762 MN416722 MN418842 MN418688 
A/swine/Jiangsu/89/2011(H1N1) MN416363 MN416450 MN416550 MN416623 MN418767 MN416727 MN418847 MN418693 
A/swine/Jilin/63/2011(H1N1) MN416371 MN416458 MN416558 MN416631 MN418775 MN416735 MN418855 MN418701 
A/swine/Tianjin/137/2011(H1N1) MN416392 MN416479 MN416579 MN416652 MN418796 MN416756 MN418876 MN418722 
A/swine/Beijing/731/2012(H1N1) MN416332 MN416419 MN416519 MN416592 MN418736 MN416696 MN418816 MN418662 
A/swine/Beijing/951/2012(H1N1) MN416334 MN416421 MN416521 MN416594 MN418738 MN416698 MN418818 MN418664 
A/swine/Hebei/156/2012(H1N1) MN416340 MN416427 MN416527 MN416600 MN418744 MN416704 MN418824 MN418670 
A/swine/Hebei/350/2012(H1N1) MN416342 MN416429 MN416529 MN416602 MN418746 MN416706 MN418826 MN418672 
A/swine/Hebei/535/2012(H1N1) MN416344 MN416431 MN416531 MN416604 MN418748 MN416708 MN418828 MN418674 
A/swine/Hebei/561/2012(H1N1) MN416345 MN416432 MN416532 MN416605 MN418749 MN416709 MN418829 MN418675 
A/swine/Henan/08/2012(H1N1) MN416351 MN416438 MN416538 MN416611 MN418755 MN416715 MN418835 MN418681 
A/swine/Henan/20/2012(H1N1) MN416353 MN416440 MN416540 MN416613 MN418757 MN416717 MN418837 MN418683 
A/swine/Henan/458/2012(H1N1) MN416356 MN416443 MN416543 MN416616 MN418760 MN416720 MN418840 MN418686 
A/swine/Liaoning/408/2012(H1N1) MN416373 MN416460 MN416560 MN416633 MN418777 MN416737 MN418857 MN418703 
A/swine/Liaoning/458/2012(H1N1) MN416374 MN416461 MN416561 MN416634 MN418778 MN416738 MN418858 MN418704 
A/swine/Liaoning/590/2012(H1N1) MN416375 MN416462 MN416562 MN416635 MN418779 MN416739 MN418859 MN418705 
A/swine/Liaoning/896/2012(H1N1) MN416376 MN416463 MN416563 MN416636 MN418780 MN416740 MN418860 MN418706 
A/swine/Shandong/436/2012(H1N1) MN416387 MN416474 MN416574 MN416647 MN418791 MN416751 MN418871 MN418717 
A/swine/Tianjin/741/2012(H1N1) MN416395 MN416482 MN416582 MN416655 MN418799 MN416759 MN418879 MN418725 
A/swine/Tianjin/960/2012(H1N1) MN416398 MN416485 MN416585 MN416658 MN418802 MN416762 MN418882 MN418728 
A/swine/Hebei/T37/2013(H1N1) MN416346 MN416433 MN416533 MN416606 MN418750 MN416710 MN418830 MN418676 
A/swine/Henan/727/2013(H1N1) MN416357 MN416444 MN416544 MN416617 MN418761 MN416721 MN418841 MN418687 
A/swine/Jilin/625/2013(H1N1) MN416370 MN416457 MN416557 MN416630 MN418774 MN416734 MN418854 MN418700 
A/swine/Jilin/665/2013(H1N1) MN416372 MN416459 MN416559 MN416632 MN418776 MN416736 MN418856 MN418702 
A/swine/Liaoning/950/2013(H1N1) MN416377 MN416464 MN416564 MN416637 MN418781 MN416741 MN418861 MN418707 
A/swine/Liaoning/D66/2013(H1N1) MN416378 MN416465 MN416565 MN416638 MN418782 MN416742 MN418862 MN418708 
A/swine/Shandong/39/2013(H1N1) MN416386 MN416473 MN416573 MN416646 MN418790 MN416750 MN418870 MN418716 
A/swine/Shandong/862/2013(H1N1) MN416388 MN416475 MN416575 MN416648 MN418792 MN416752 MN418872 MN418718 
A/swine/Tianjin/525/2013(H1N1) MN416394 MN416481 MN416581 MN416654 MN418798 MN416758 MN418878 MN418724 
A/swine/Tianjin/9/2013(H1N1) MN416397 MN416484 MN416584 MN416657 MN418801 MN416761 MN418881 MN418727 
A/swine/Shandong/S113/2014(H1N1) KP735701 KP735705 KP735709 KP735713 KP735717 KP735721 KP735725 KP735729 
A/swine/Shandong/S153/2014(H1N1) KP735702 KP735706 KP735710 KP735714 KP735718 KP735722 KP735726 KP735730 
A/swine/Shandong/S269/2014(H1N1) KP735703 KP735707 KP735711 KP735715 KP735719 KP735723 KP735727 KP735731 
A/swine/Shandong/S93/2014(H1N1) KP735700 KP735704 KP735708 KP735712 KP735716 KP735720 KP735724 KP735728 
A/swine/Anhui/1227/2015(H1N1) MN416328 MN416415 MN416515 MN416588 MN418732 MN416692 MN418812 MN418658 
A/swine/Tianjin/158/2015(H1N1) MN416393 MN416480 MN416580 MN416653 MN418797 MN416757 MN418877 MN418723 
A/swine/Tianjin/78/2015(H1N1) MN416396 MN416483 MN416583 MN416656 MN418800 MN416760 MN418880 MN418726 
A/swine/Heilongjiang/1214/2016(H1N1) MN416349 MN416436 MN416536 MN416609 MN418753 MN416713 MN418833 MN418679 
A/swine/Jilin/21/2016(H1N1) MN416367 MN416454 MN416554 MN416627 MN418771 MN416731 MN418851 MN418697 
A/swine/Jilin/23/2016(H1N1) MN416368 MN416455 MN416555 MN416628 MN418772 MN416732 MN418852 MN418698 
A/swine/Jilin/29/2016(H1N1) MN416369 MN416456 MN416556 MN416629 MN418773 MN416733 MN418853 MN418699 
A/swine/Shandong/1203/2016(H1N1) MN416382 MN416469 MN416569 MN416642 MN418786 MN416746 MN418866 MN418712 
A/swine/Shandong/1207/2016(H1N1) MN416383 MN416470 MN416570 MN416643 MN418787 MN416747 MN418867 MN418713 
A/swine/Shandong/16/2016(H1N1) MN416384 MN416471 MN416571 MN416644 MN418788 MN416748 MN418868 MN418714 
A/swine/Shandong/36/2016(H1N1) MN416385 MN416472 MN416572 MN416645 MN418789 MN416749 MN418869 MN418715 
A/swine/Shandong/9/2016(H1N1) MN416389 MN416476 MN416576 MN416649 MN418793 MN416753 MN418873 MN418719 
A/swine/Hebei/0113/2017(H1N1) MN416336 MN416423 MN416523 MN416596 MN418740 MN416700 MN418820 MN418666 
A/swine/Hebei/0116/2017(H1N1) MN416337 MN416424 MN416524 MN416597 MN418741 MN416701 MN418821 MN418667 
A/swine/Hebei/0221/2017(H1N1) MN416338 MN416425 MN416525 MN416598 MN418742 MN416702 MN418822 MN418668 
A/swine/Heilongjiang/0110/2017(H1N1) MN416347 MN416434 MN416534 MN416607 MN418751 MN416711 MN418831 MN418677 
A/swine/Heilongjiang/0140/2017(H1N1) MN416348 MN416435 MN416535 MN416608 MN418752 MN416712 MN418832 MN418678 
A/swine/Shandong/0334/2017(H1N1) MN416379 MN416466 MN416566 MN416639 MN418783 MN416743 MN418863 MN418709 
A/swine/Shandong/0336/2017(H1N1) MN416380 MN416467 MN416567 MN416640 MN418784 MN416744 MN418864 MN418710 
A/swine/Shandong/0337/2017(H1N1) MN416381 MN416468 MN416568 MN416641 MN418785 MN416745 MN418865 MN418711 
A/swine/Shandong/JM78/2017(H1N1) MN416390 MN416477 MN416577 MN416650 MN418794 MN416754 MN418874 MN418720 
A/swine/Shandong/LY142/2017(H1N1) MN416391 MN416478 MN416578 MN416651 MN418795 MN416755 MN418875 MN418721 
A/swine/Anhui/0202/2018(H1N1) MN416326 MN416413 MN416513 MN416586 MN418730 MN416690 MN418810 MN418656 
A/swine/Anhui/0203/2018(H1N1) MN416327 MN416414 MN416514 MN416587 MN418731 MN416691 MN418811 MN418657 
A/swine/Beijing/0301/2018(H1N1) MN416329 MN416416 MN416516 MN416589 MN418733 MN416693 MN418813 MN418659 
A/swine/Henan/SN10/2018(H1N1) MN416359 MN416446 MN416546 MN416619 MN418763 MN416723 MN418843 MN418689 
A/swine/Henan/SN11/2018(H1N1) MN416360 MN416447 MN416547 MN416620 MN418764 MN416724 MN418844 MN418690 





Table S3. Cont. 
Strain name PB2 PB1 PA HA NP NA M NS 
A/swine/Henan/SN13/2018(H1N1) MN416362 MN416449 MN416549 MN416622 MN418766 MN416726 MN418846 MN418692 
A/swine/Jiangsu/J004/2018(H1N1) MN416364 MN416451 MN416551 MN416624 MN418768 MN416728 MN418848 MN418694 
A/swine/Jiangsu/J005/2018(H1N1) MN416365 MN416452 MN416552 MN416625 MN418769 MN416729 MN418849 MN418695 







Table S4. Clinical symptoms of ferrets infected with influenza viruses 
 
 
Virus (genotype)  






No. with lung lesion 
(mean pulmonary con-
solidation area, %) 
No. with weight loss 
(mean maximum 
weight loss, %) 
 





SW/HN/08/11 (G1 EA)      
Inoculated 3/3 (0.8) 3/3 3/3 (8.5) 3/3 (4.2) 3/3 3/3 (160, 320, 320) 
DC contact 0/3 0/3 0/3 0/3 0/3 0/3 
RD contact 0/3 0/3 0/3 0/3 0/3 0/3 
SW/HB/T37/13 (G1 EA)      
Inoculated 3/3 (1.1) 3/3 3/3 (9.3) 3/3 (5.6) 3/3 3/3 (320, 320, 320) 
DC contact 0/3 0/3 0/3 0/3 0/3 0/3 
RD contact 0/3 0/3 0/3 0/3 0/3 0/3 
SW/SD/1207/16 (G4 EA)      
Inoculated 3/3 (1.6) 3/3 3/3 (25.5) 3/3 (8.6) 3/3 3/3 (320, 320, 320) 
DC contact 3/3 (1.3) 3/3 3/3 (23.4) 3/3 (8.4) 3/3 3/3 (160, 160, 80) 
RD contact 3/3 (1.3) 3/3 3/3 (22.6) 3/3 (7.1) 3/3 3/3 (160, 80, 80) 
SW/HB/0116/17 (G4 EA)      
Inoculated 3/3 (1.4) 3/3 3/3 (19.4) 3/3 (7.3) 3/3 3/3 (160, 320, 320) 
DC contact 3/3 (1.2) 3/3 3/3 (17.5) 3/3 (6.6) 3/3 3/3 (160, 80, 80) 
RD contact 3/3 (1.3) 1/3 1/3 (16.7) 3/3 (6.2) 1/3 1/3 (160) 
SW/HN/SN13/18 (G4 EA)      
Inoculated 3/3 (1.8) 3/3 3/3 (37.1) 3/3 (9.8) 3/3 3/3 (160, 320, 160) 
DC contact 3/3 (1.6) 3/3 3/3 (24.5) 3/3 (8.7) 3/3 3/3 (160, 80, 80) 
RD contact 3/3 (1.7) 3/3 3/3 (22.3) 3/3 (7.4) 3/3 3/3 (80, 160, 160) 
SW/JS/J004/18 (G4 EA)      
Inoculated 3/3 (1.6) 3/3 3/3 (21.8) 3/3 (9.1) 3/3 3/3 (320, 160, 160) 
DC contact 3/3 (1.5) 3/3 3/3 (23.4) 3/3 (8.6) 3/3 3/3 (160, 160, 80) 
RD contact 3/3 (1.4) 3/3 3/3 (19.5) 3/3 (8.2) 3/3 3/3 (160, 160, 160) 
CA04 (pdm/09 H1N1)      
Inoculated 3/3 (0.9) 3/3 3/3 (5.2) 3/3 (4.4) 3/3 3/3 (320, 160, 320) 
DC contact 3/3 (0.8) 3/3 3/3 (4.5) 3/3 (4.0) 3/3 3/3 (160, 160, 160) 
RD contact 3/3 (0.8) 3/3 3/3 (4.0) 3/3 (3.8) 3/3 3/3 (160, 80, 80) 








Table S5. Antigenic classification of EA H1N1 SIVs by HI assays* 
 Antisera 
 











A/Michigan/45/2015 (pdm/09 H1N1) - - - - 2560† 
A      
SW/HN/08/11 (G1 EA H1N1) 2560† 1280 160 80 320 
SW/HB/T37/13 (G1 EA H1N1) 2560 2560† 80 80 160 
SW/BJ/731/12 (G1 EA H1N1) 1280 2560 80 160 160 
SW/LN/458/12 (G1 EA H1N1) 2560 2560 80 80 160 
B      
SW/SD/1207/16 (G4 EA H1N1) 80 80 2560† 2560 20 
SW/HN/SN13/18 (G4 EA H1N1) 80 160 2560 2560† 40 
SW/JL/23/16 (G4 EA H1N1) 80 320 5120 2560 40 
SW/HLJ/1214/16 (G4 EA H1N1) 160 160 1280 1280 < 
SW/SD/0334/17 (G4 EA H1N1) 80 40 1280 1280 < 
SW/HLJ/0140/17 (G4 EA H1N1) 160 160 1280 5120 20 
SW/HB/0113/17 (G4 EA H1N1) 80 80 2560 2560 40 
SW/HB/0116/17 (G4 EA H1N1) 160 160 2560 2560 20 
SW/SD/0336/17 (G4 EA H1N1) 80 40 1280 1280 20 
SW/JS/J004/18 (G4 EA H1N1) 80 40 2560 2560 20 
*Virus names are abbreviated as isolation location, strain name and collection year. Data represent HI titers. High HI titers (≥ 
640) are shaded black, moderate HI titers (160, 320) are gray and low HI titers (40, 80) are not shaded. Titers < 20 are indicated 







Table S6. Amino acid differences in the antigenic sites of the HA molecule of the H1N1 viruses 
(H1 numbering) 
  Amino acid in the antigenic site 
  Site Sa Site Sb 
Virus Genotype 124 125 155 157 159 160 162 163 164 153 156 185 189 190 193 195 
A/swine/Henan/08/2011 G1 EA  P N G S P K S K S K N Y Q T Q N 
A/swine/Hebei/T37/2013 G1 EA P N G S P K S K S K N D Q T Q N 
A/swine/Beijing/731/2012 G1 EA P N G S P K S K S K N D Q T Q N 
A/swine/Liaoning/458/2012 G1 EA P N G S P K S K S K N D Q T Q N 
A/swine/Shandong/1207/2016 G4 EA P N G S P K S K S K N E Q T Q N 
A/swine/Henan/SN13/2018 G4 EA P N G S P K S K S K N D Q T Q N 
A/swine/Jilin/23/2016 G4 EA P N G S P K S K S K N D Q T Q N 
A/swine/Heilongjiang/1214/2016 G4 EA P N G S P K S K S K N E Q T Q N 
A/swine/Shandong/0334/2017 G4 EA P N G S P K S K S K N E Q T Q N 
A/swine/Heilongjiang/0140/2017 G4 EA P N G S P K S K S K N E Q T Q N 
A/swine/Hebei/0113/2017 G4 EA P N G S P K S K S K N E Q T Q N 
A/swine/Hebei/0116/2017 G4 EA P N G S P K S K S K N E Q T Q N 
A/swine/Shandong/0336/2017 G4 EA P N G S P K S K S K N E Q T Q N 
A/swine/Jiangsu/J004/2018 G4 EA P N G S P K S K S K N D Q T Q N 
A/Michigan/45/2015 pdm/09 P N G S P K N Q S K N T Q S Q A 
 
  Amino acid in the antigenic site 
  Site Ca1 Site Ca2 Site Cb 
Virus Genotype 166 170 204 237 135 137 140 142 221 222 70 71 73 74 75 115 
A/swine/Henan/08/2011 G1 EA  T G S G A S G N R E L L A N S E 
A/swine/Hebei/T37/2013 G1 EA T G S G A S G N R E L L A N S E 
A/swine/Beijing/731/2012 G1 EA T G S G A S G N R E L L A N S E 
A/swine/Liaoning/458/2012 G1 EA T G S G A S G N R E L L A N S E 
A/swine/Shandong/1207/2016 G4 EA T G S G A S G N R E L L A N S E 
A/swine/Henan/SN13/2018 G4 EA T G T G S S G N R E L L A N S E 
A/swine/Jilin/23/2016 G4 EA T G S G S S G N R G L L A N S E 
A/swine/Heilongjiang/1214/2016 G4 EA T G S G S S G N R E L L A N S E 
A/swine/Shandong/0334/2017 G4 EA T G S G A S G N R E L L A N S E 
A/swine/Heilongjiang/0140/2017 G4 EA T G S G A S G N R E L L A N S E 
A/swine/Hebei/0113/2017 G4 EA T G S G A S G N R E L L A N S E 
A/swine/Hebei/0116/2017 G4 EA T G S G A S G N R E L L A N S E 
A/swine/Shandong/0336/2017 G4 EA T G S G A S G N R E L L A N S E 
A/swine/Jiangsu/J004/2018 G4 EA T G S G A S G N R K L L A N S E 







Table S7. Summary of the serological survey of the workers from 15 swine farms by HI assay 
during 2016–2018 












2016 A1 23 4.3 (1) 8.7 (2) 52.2 (12) 
 A2 20 5.0 (1) 5.0 (1) 30.0 (6) 
 A3 17 0 (0) 5.9 (1) 29.4 (5) 
 A4 20 10.0 (2) 10.0 (2) 50.0 (10) 
 A5 10 0 (0) 0 (0) 40.0 (4) 
Total  90 4.4 (4) 6.7 (6) 41.1 (37) 
2017 B1 29 10.3 (3) 17.2 (5) 44.8 (13) 
 B2 21 19.0 (4) 19.0 (4) 33.3 (7) 
 B3 30 10.0 (3) 13.3 (4) 43.3 (13) 
 B4 26 3.8 (1) 3.8 (1) 19.2 (5) 
 B5 14 0 (0) 0 (0) 14.3 (2) 
Total  120 9.2 (11) 11.7 (14) 33.3 (40) 
2018 C1 25 8.0 (2) 8.0 (2) 48.0 (12) 
 C2 29 3.4 (1) 6.9 (2) 34.5 (10) 
 C3 26 7.7 (2) 15.4 (4) 42.3 (11) 
 C4 29 6.9 (2) 17.2 (5) 44.8 (13) 
 C5 19 0 (0) 10.5 (2) 42.1 (8) 
Total  128 5.5 (7) 11.7 (15) 42.2 (54) 
All 3 years 15 338 6.5 (22) 10.4 (35) 38.8 (131) 






Table S8. Characteristics of swine workers upon enrolment and odds ratios for seroprevalence of 
reference strains 
 % Pos (No. positive) | OR (95% CI)ǂ 
Group (No. total) SW/HN/08/11 (G1) SW/SD/1207/16 (G4) A/Michigan/45/2015 (pdm/09) 
Gender    
Male (202) 6.9 (14) | 1.2 (0.5-2.9) 10.9 (22) | 1.2 (0.6-2.4) 41.1 (83) | 1.3 (0.8-2.0) 
Female# (136) 5.9 (8)   | Ref 9.6 (13)   | Ref 35.3 (48) | Ref 
    
Age (years)    
18–35 (44) 9.1 (4)   | 1.6 (0.5-5.2) 20.5* (9) | 3.2 (1.3-7.7) 54.5 (24) | 2.2 (1.1-4.1) 
36–45 (51) 7.8 (4)   | 1.4 (0.4-4.4) 15.7 (8)  | 2.3 (1.0-5.7) 39.2 (20) | 1.2 (0.6-2.2) 
> 45# (243) 5.8 (14) | Ref 7.4 (18)  | Ref 35.8 (87) | Ref 
    
Collection year    
2016# (90) 4.4 (4)   | Ref 6.7 (6)     | Ref 41.1 (37) | Ref 
2017 (120) 9.2 (11) | 2.2 (0.7-7.1) 11.7 (14) | 1.8 (0.7-5.0) 33.3 (40) | 0.7 (0.4-1.3) 
2018 (128) 5.5 (7)   | 1.2 (0.4-4.4) 11.7 (15) | 1.9 (0.7-5.0) 42.2 (54) | 1.0 (0.6-1.8) 
ǂOdds ratio and 95% confidence interval compared to the control group. 







Table S9. Detailed data of positive serum samples of swine workers 






















2016 1 <  <  80  2017 6 <  <  40 
2016 1 <  <  40  2017 6 <  40 <  
2016 1 <  40 80  2017 6 <  <  40 
2016 1 <  <  80  2017 6 <  <  40 
2016 1 <  <  80  2017 6 <  40 40 
2016 1 <  <  80  2017 6 <  <  40 
2016 1 <  <  40  2017 6 <  <  160 
2016 1 <  <  80  2017 6 <  <  80 
2016 1 <  <  40  2017 6 <  <  40 
2016 1 <  <  40  2017 6 <  40 80 
2016 1 40 40 160  2017 7 <  <  40 
2016 1 <  <  80  2017 7 <  <  80 
2016 2 <  <  160  2017 7 <  <  40 
2016 2 <  <  40  2017 7 160 40 160 
2016 2 <  <  40  2017 7 40 40 <  
2016 2 160 80 160  2017 7 40 40 160 
2016 2 <  <  40  2017 7 40 40 <  
2016 2 <  <  80  2017 7 <  <  40 
2016 3 <  <  40  2017 7 <  <  40 
2016 3 <  <  40  2017 8 <  <  40 
2016 3 <  <  40  2017 8 <  <  80 
2016 3 <  <  40  2017 8 <  <  80 
2016 3 <  160 80  2017 8 160 160 320 
2016 4 <  <  80  2017 8 40 40 80 
2016 4 <  <  40  2017 8 <  <  40 
2016 4 <  <  80  2017 8 <  <  40 
2016 4 <  <  40  2017 8 <  <  40 
2016 4 <  <  40  2017 8 <  <  80 
2016 4 <  <  80  2017 8 <  <  80 
2016 4 40 40 160  2017 8 <  40 <  
2016 4 <  <  40  2017 8 <  <  40 
2016 4 40 80 640  2017 8 40 <  40 
2016 4 <  <  160  2017 8 <  40 160 
2016 5 <  <  80  2017 9 40 40 40 
2016 5 <  <  80  2017 9 <  <  40 
2016 5 <  <  40  2017 9 <  <  40 
2016 5 <  <  80  2017 9 <  <  40 
2017 6 <  <  80  2017 9 <  <  40 
2017 6 40 <  <   2017 10 <  <  40 
2017 6 80 80 160  2017 10 <  <  40 
2017 6 40 80 160  2018 11 <  <  40 





Table S9. Cont. 






















2018 11 <  <  160  2018 13 <  <  40 
2018 11 <  <  80  2018 13 640 1280 1280 
2018 11 <  <  40  2018 13 <  <  160 
2018 11 <  <  320  2018 13 <  80 160 
2018 11 <  <  80  2018 14 <  <  80 
2018 11 <  <  40  2018 14 <  <  40 
2018 11 40 40 80  2018 14 <  <  320 
2018 11 80 80 640  2018 14 <  <  40 
2018 11 <  <  80  2018 14 <  40 320 
2018 11 <  <  40  2018 14 <  <  80 
2018 12 <  <  160  2018 14 40 80 80 
2018 12 <  <  40  2018 14 <  40 <  
2018 12 <  160 <   2018 14 <  <  40 
2018 12 <  <  160  2018 14 <  80 <  
2018 12 <  <  40  2018 14 <  <  40 
2018 12 <  <  40  2018 14 <  <  40 
2018 12 <  <  40  2018 14 <  <  40 
2018 12 <  <  80  2018 14 80 80 80 
2018 12 160 160 640  2018 14 <  <  80 
2018 12 <  <  40  2018 15 <  <  40 
2018 12 <  <  40  2018 15 <  <  80 
2018 13 <  <  40  2018 15 <  40 160 
2018 13 <  <  80  2018 15 <  <  80 
2018 13 <  <  40  2018 15 <  40 160 
2018 13 <  40 320  2018 15 <  <  160 
2018 13 40 40 160  2018 15 <  <  40 
2018 13 <  <  80  2018 15 <  <  40 







Table S10. Detailed data of positive serum samples of common household population 


















2016 <  <  40  2017 <  <  80 
2016 <  <  80  2017 <  40 160 
2016 <  <  40  2017 <  <  40 
2016 <  <  40  2017 <  <  40 
2016 <  <  40  2017 <  <  40 
2016 <  <  40  2017 <  <  40 
2016 <  <  40  2017 <  <  40 
2016 <  <  320  2017 <  <  40 
2016 <  40 320  2017 <  <  40 
2016 <  40 320  2017 40 40 160 
2016 <  <  80  2017 <  <  40 
2016 <  <  80  2017 <  <  80 
2016 <  <  40  2017 <  <  40 
2016 <  40 <   2018 40 80 160 
2016 <  <  80  2018 160 320 320 
2016 <  <  40  2018 <  <  320 
2016 <  <  40  2018 <  <  40 
2016 40 40 320  2018 <  <  40 
2016 <  <  160  2018 <  <  40 
2016 <  <  320  2018 <  <  80 
2016 <  <  160  2018 <  <  40 
2016 <  <  320  2018 <  <  40 
2016 <  <  320  2018 <  <  40 
2016 <  <  160  2018 <  <  40 
2016 40 40 <   2018 <  <  80 
2016 <  <  40  2018 <  <  40 
2016 <  <  40  2018 <  <  40 
2016 <  <  80  2018 <  <  40 
2016 <  <  320  2018 <  <  40 
2016 <  <  80  2018 <  <  40 
2016 <  <  320  2018 <  <  160 
2017 <  <  80  2018 <  <  40 
2017 <  <  40  2018 <  <  40 
2017 <  <  320  2018 <  <  40 
2017 <  <  80  2018 <  <  80 
2017 <  <  80  2018 <  40 80 
2017 <  <  40  2018 <  <  40 
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